ابحث في العناوين

“obesity”

Most powerful obesity drug yet: People lost up to 25% of weight in trial

Researchers published late-stage clinical trial data today for the latest obesity drug, retatrutide—expected to be the most powerful formula yet—and the results appear in line with high expectations. Patients with obesity on the highest retatrutide dose lost an average of 25 perc

Ars Technica - All content · ٢٩ سبتمبر ٢٠٢٦، ١٠:٣٠ م

العلوم والبيئة

Why rheumatoid arthritis pain may persist even when inflammation is under control

Pain and fatigue in rheumatoid arthritis can persist even after inflammation improves, with depression, poor sleep, obesity, smoking, and chronic pain potentially helping sustain symptoms. Researchers say identifying these hidden drivers could prevent unnecessary medication chang

All Top News -- ScienceDaily · ٢٧ سبتمبر ٢٠٢٦، ١٠:٤٩ ص

الأعمال والاقتصاد

Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s

As Novo works to turn itself around, some analysts say Lilly has advantages that could help it maintain its position at the top of the obesity drug market.

Business News · ٢٥ سبتمبر ٢٠٢٦، ١٢:٥١ م